Streetbeat News

Earnings

NLR

URA

URNM

UUUU

Energy Fuels (AMEX:UUUU) plans to open two uranium mines in Colorado and Wyoming, potentially doubling its uranium output to over two million pounds annually by 2025. The company reported a net income of nearly $100 million in 2023 and contracted sales of 100,000 pounds at $102.88 per pound in Q1 2024. Energy Fuels is also focusing on exploration and permitting for future production. Additionally, three ETFs, Global X Uranium ETF (NYSE:URA), North Shore Global Uranium Mining ETF (NYSE:URNM), and VanEck Vectors Uranium+Nuclear Energy ETF (NYSE:NLR), offer investment opportunities in the uranium sector.

Portfolio Pulse from Stjepan Kalinic

February 27, 2024 | 5:10 pm

SEZL

Sezzle shares surged following the announcement of its Q4 financial results and the issuance of FY24 guidance, indicating a positive outlook.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 5:03 pm

SPCE

Virgin Galactic Holdings Inc (NYSE:SPCE) is set to report its Q4 financial results, with analysts expecting a revenue of $2.98 million and a loss of 30 cents per share. The company has previously beaten revenue estimates in 8 of the last 10 quarters but has a mixed record on earnings per share. Analysts have mixed views, with Morgan Stanley downgrading the stock due to a pause in space flights, while Truist Securities upgraded it. Key items for investors include updates on flight schedules, reservations, and the company's financial health. SPCE shares are currently up 5.06% at $1.87.

Portfolio Pulse from Chris Katje

February 27, 2024 | 5:02 pm

LPSN

LivePerson (NASDAQ:LPSN) is scheduled to release its quarterly earnings report on February 28, 2024, with an expected EPS of $-0.31. Analysts and investors will be closely watching for any earnings beat and positive guidance for future growth. Historical data shows significant stock price movements following earnings announcements, with a notable 11.07% drop after last quarter's miss. Over the past year, LPSN shares have declined by 71.91%, indicating potential concern among long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 5:02 pm

NRG

NRG Energy (NYSE:NRG) is scheduled to release its quarterly earnings report on February 28, 2024. Analysts predict an EPS of $3.01. The focus will be on whether NRG beats this estimate and provides positive guidance for the next quarter. Historical data shows mixed results in NRG's ability to meet EPS estimates, with a notable miss last quarter leading to a slight stock price drop. Over the past year, NRG shares have increased by 62.3%, indicating strong long-term shareholder returns.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 5:01 pm

STR

Sitio Royalties (NYSE:STR) is scheduled to release its quarterly earnings report on February 28, 2024, with an expected EPS of $0.16. Analysts and investors are particularly interested in the company's guidance for future growth. Sitio Royalties' past earnings performance shows a mix of misses and beats, with the stock price reacting accordingly. Currently, shares are trading at $21.78, reflecting a 9.38% decline over the last 52 weeks.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 5:01 pm

OSW

OneSpaWorld Holdings (NASDAQ:OSW) is scheduled to release its quarterly earnings report on February 28, 2024, with an estimated EPS of $0.17. Historical data shows positive stock price reactions to earnings beats. Shares are currently trading at $13.78, reflecting a 21.47% increase over the last 52 weeks. Investors are optimistic but will focus on the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 5:01 pm

BRP

BRP Group (NASDAQ:BRP) is scheduled to release its quarterly earnings report on February 28, 2024, with an expected EPS of $0.11. Analysts and investors will be looking for the company to beat this estimate and provide positive guidance for future growth. Historical data shows that BRP Group's stock price has been sensitive to earnings performance and guidance, with a notable 12.07% drop after last quarter's earnings beat. The stock is currently trading at $26.41, down 1.74% over the last year, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 5:01 pm

CRNX

Crinetics Pharmaceuticals (NASDAQ:CRNX) is scheduled to release its quarterly earnings report on February 28, 2024, with an estimated EPS of $-0.86. Analysts and investors will be looking for the company to beat this estimate and provide positive guidance for the next quarter. Historical data shows that the company's stock price reacts to both earnings performance and guidance. Last quarter, CRNX missed its EPS estimate by $0.10, resulting in a 3.62% drop in its share price. Over the last year, CRNX shares have increased by 100.99%, trading at $38.67 as of February 26.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 5:01 pm

DH

Definitive Healthcare (NASDAQ:DH) is scheduled to release its quarterly earnings report on February 28, 2024, with an expected EPS of $0.08. Historically, the company has surpassed EPS estimates, leading to significant share price movements. Last quarter, DH beat the EPS estimate by $0.03, resulting in a 19.97% share price increase the following day. Over the past year, DH shares have declined by 16.33%, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 5:01 pm